Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Amrita School of Ayurveda and Rashtriya Ayurveda Vidyapeeth, Ministry of AYUSH sign MoU to create a repository of clinical cases in Ayurveda - The Pharma Times | Pharma & Health Care News Portal
Latest

Amrita School of Ayurveda and Rashtriya Ayurveda Vidyapeeth, Ministry of AYUSH sign MoU to create a repository of clinical cases in Ayurveda

  • Collaboration for publication in AyurCeL portal of selected clinical case reports of Certificate course of RAV (CRAV) students between Amrita School of Ayurveda and Rashtriya Ayurveda Vidyapeeth (RAV)
  • Amrita School of Ayurveda to provide model case report training to RAV Gurus and Shishyas
  • Acknowledgement of RAV contributions in all publications and reports utilizing their data
  • Modality of data exchange and finance to be determined via mutual consultation and agreement

New Delhi, March 31, 2023: Amrita School of Ayurveda and Rashtriya Ayurveda Vidyapeeth, Ministry of AYUSH have signed a Memorandum of Understanding (MoU) to further develop the AyurCeL (online portal) and create a repository of clinical cases in Ayurveda. This collaboration will facilitate the generation of practice-based evidence by helping clinicians report clinical outcomes systematically supported by multimedia. The MoU was signed by Dr. Kousthubha Upadhyaya on behalf of Rashtriya Ayurved Vidyapeeth and Swami Sankaramritananda Puri on behalf of Amrita School of Ayurveda.

The Ayurveda Clinical e-Learning (AYURCeL) project aims to fill this gap by creating a web platform to make available the clinical experiences of successful Ayurveda clinicians in a digital form and format that will facilitate continuous clinical learning based on well-documented case studies.

Under the MoU, the collaboration between Amrita School of Ayurveda, Kerala, and RAV (Rashtriya Ayurveda Vidyapeeth), will be established in the area of mutual interest to both the institutions for submission of selected clinical case reports of the Certificate course of RAV (CRAV) students after due verification from their corresponding Gurus to the AyurCeL portal for preliminary screening every month. The Amrita School of Ayurveda, Kerala shall examine the submitted cases as per their selection criterion and update the case report and further follow-ups and after vetting done by the experts shall publish the report in the portal.

Furthermore, the Amrita School of Ayurveda, Kerala will arrange for the training for RAV- Gurus and Shishyas for preparing model Case Reports. The RAV shall organize such training programs after mutual consultation and agreement. The modalities of data exchange including finance may be evolved and decided by both institutes after mutual consultation and agreement. Both institutes will respect and obey regulations of each other on a mutual basis.

Dr. P Rammanohar, Principal Investigator of the project and Research Director, Amrita Centre for Advanced Research in Ayurveda (ĀCĀRA), School of Ayurveda said, “The first step to generate evidence is from clinical practice. AyurCeL will facilitate the generation of practice-based evidence by helping clinicians report clinical outcomes systematically supported by multimedia. AyurCeL aids clinicians to transform their clinical notes into a systematic documentation. Thus, this tool will become very helpful for busy clinicians. This collaboration will prove to be a boon for the Ayurveda fraternity nationally as it will create a repository of clinical cases in Ayurveda, which will greatly help the research and development of the Ayurvedic system of medicine. The AyurCeL portal will acknowledge the contributions of RAV in all publications and reports in which information is sourced through data provided by RAV.”

The modalities of exchange of data including finance may be evolved and decided by both institutes after mutual consultation and agreement. Both institutes will respect and obey regulations of each other on a mutual basis.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

21 hours ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

2 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

3 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

4 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

7 days ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420